Vilon
Lys-Glu · KE · C11H21N3O5 · monoisotopic 275.1481 Da. The index holds 11 assay reports on this compound across 1 batches from 1 suppliers.
Analytical fingerprint
Hand-authored chemistry. These properties describe the substance and do not change when a record is added.
A dipeptide, and effectively unretained on C18 at 3.94 min. Reverse-phase purity on vilon measures almost nothing; the index accepts vilon reports only where a HILIC or ion-pair method was used and records C18-only submissions as method-inappropriate. Twelve of the nineteen vilon reports on file fall into that category, which is why the compound's headline median is published with a method caveat rather than a low-n caveat.
- Compound class
- Short bioregulator peptides
- Molecular formula
- C11H21N3O5
- Monoisotopic mass
- 275.1481Da
- Average mass
- 275.30Da
- Residues
- 2
- Nominal retention (RG-2, 30 min)
- 3.94min
- Retention window
- 0.20min
- Counter-ion as usually shipped
- acetate
- Typical label claims
- 10 mg · 20 mg
- Analytical difficulty (index scale)
- 0.80 — straightforward
- Purity is a defined quantity
- YES
Representative chromatogram
Drawn from this page's own medians. Not a scan, not an illustration, and not any single report.
What the index has observed
Arithmetic over the 11 records the index holds. Aggregates on this page are computed over the records the index holds, which are not a random sample of the material on the market. Lots that get tested are lots someone chose to test. Read every figure here as a description of this dataset rather than as an estimate of a population.
Fewer than twelve purity records (n=11) — a histogram of this would be a picture of the sample size rather than of the compound. The individual values are in the table below.
Characteristic impurities and degradants
The left three columns are authored chemistry — what this molecule characteristically carries and where it elutes. The right three are what the index has actually reported.
| Named species | ΔRT (min, RG-2) | Δ mass (Da) | Seen in | Median % area | Max % area |
|---|---|---|---|---|---|
| free lysine (−129 Da) | -0.24 | -129.043 | 100% | 0.09 | 0.34 |
| free glutamic acid (−128 Da) | -0.30 | -128.095 | 100% | 0.23 | 0.65 |
| diketopiperazine (−18 Da) | +0.10 | -18.011 | 100% | 0.13 | 0.79 |
| Lys-Glu-Lys tripeptide (+128 Da) | +0.14 | +128.095 | 100% | 0.12 | 0.22 |
Degradation pathways
- diketopiperazine formation
- hydrolysis to free amino acids
Full impurity profile, with what each named species implies about the synthesis →
Quarterly coverage
Most recent records
| Report | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020570 | SSA | SSA-2508-B6325 | Nordanalyt | 2025-Q3 | 99.13 | 6.08 | 94.9 | Supplier-supplied | 0 | FAIL |
| AX-2025-020569 | SSA | SSA-2508-B6325 | Janoshik | 2025-Q3 | 99.74 | 5.87 | 97.7 | Supplier-supplied | 0 | FAIL |
| AX-2025-020568 | SSA | SSA-2508-B6325 | Nordanalyt | 2025-Q3 | 99.46 | 5.77 | 105.5 | Supplier-supplied | 0 | FAIL |
| AX-2025-020566 | SSA | SSA-2508-B6325 | VendorInvestigate | 2025-Q3 | 99.04 | 5.78 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-020571 | SSA | SSA-2508-B6325 | PeptideMeter | 2025-Q3 | 99.51 | 6.38 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020562 | SSA | SSA-2508-B6325 | Janoshik | 2025-Q3 | 99.04 | 5.35 | 104.8 | Supplier-supplied | 0 | FAIL |
| AX-2025-020567 | SSA | SSA-2508-B6325 | Janoshik | 2025-Q3 | 99.43 | 5.03 | 89.4 | Supplier-supplied | 1 | FAIL |
| AX-2025-020561 | SSA | SSA-2508-B6325 | Janoshik | 2025-Q3 | 99.15 | 6.03 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-020564 | SSA | SSA-2508-B6325 | Janoshik | 2025-Q3 | 98.96 | 5.50 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-020563 | SSA | SSA-2508-B6325 | VendorInvestigate | 2025-Q3 | 98.42 | 5.36 | 105.9 | Buyer-sourced | 1 | FAIL |
| AX-2025-020565 | SSA | SSA-2508-B6325 | Janoshik | 2025-Q3 | 99.15 | 5.46 | — | Supplier-supplied | 0 | FAIL |